Evaluation of Adults With Endocrine and Metabolic-Related Conditions

Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (NIH)
Overall Status
Recruiting
CT.gov ID
NCT02830308
Collaborator
(none)
1,250
1
161.7
7.7

Study Details

Study Description

Brief Summary

Background:

There are many endocrine and metabolic-related conditions. Two well-known disorders include diabetes and thyroid disease. Some of these diseases are caused by a change in genes. Researchers want to identify the genes involved in these disorders. They hope this will help them learn more about these diseases.

Objectives:

To learn more about conditions that affect the hormone-secreting glands (endocrine glands) in adults. To train doctors to diagnose and treat people with endocrine or metabolic conditions.

Eligibility:

Adults age 18 years and older with a known or suspected endocrine disorder.

Relatives ages 18 years and older.

Doctors will review all requests and available medical records to determine final eligibility for the protocol.

Design:

Participants will have a medical history and physical exam.

Most participants will have 1 visit, and may have follow up visits if necessary. They may have tests, surgery, or other procedures to help diagnose or treat their condition. These could include:

  • Blood, urine, and saliva tests

  • Imaging tests. These may include X-ray, ultrasound, or scans.

  • Sleep study

  • Medical photographs

  • Visits with other specialists at NIH

Participants will provide blood, urine, saliva, or tissue samples. Some of these samples may be stored in the freezer for future studies.

Participants may be asked to participate in genetic testing. They will give a blood or saliva sample for this.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This is an observational protocol designed to collect data from adult subjects with known or suspected endocrine or metabolic disorders.

    OBJECTIVE: The overall purpose of endocrine evaluations under this protocol is to increase knowledge of endocrine or metabolic diseases. Adults with known or suspected endocrine or metabolic-related condition(s) may be evaluated under this protocol for:

    1. Collection of data for endocrine related conditions (case reports, case series)

    2. Collection of data for future research

    3. Collection of samples, including leftover samples from clinically indicated tests, for future research (including genomics)

    METHODS: Patients will undergo a history and physical exam, anthropometrics, vital signs and endocrine laboratory studies.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    1250 participants
    Observational Model:
    Cohort
    Time Perspective:
    Other
    Official Title:
    Evaluation of Adults With Endocrine-Related Conditions
    Actual Study Start Date :
    Jul 9, 2016
    Anticipated Primary Completion Date :
    Dec 20, 2029
    Anticipated Study Completion Date :
    Dec 31, 2029

    Arms and Interventions

    Arm Intervention/Treatment
    Adults with known or suspected endocrine or metabolic dissorde

    Adults with known or suspected endocrine or metabolic dissorders

    Outcome Measures

    Primary Outcome Measures

    1. Recruit a diverse population of adult subjects with a known or suspected endocrine or metabolic disorder in order to provide NIDDK investigators and trainees with hands-on experience related to the diagnosis, management, treatment, and follow-up... [12/31/2036]

      The overall purpose of endocrine evaluations under this protocol is to support our clinical training and research missions.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 100 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    • INCLUSION CRITERIA:

    • Participants with known or suspected endocrine disorder age 18 years and older are eligible for this protocol. Protocol investigators will make the actual selection of subjects most appropriate for clinical evaluation.

    • Relatives ages 18 years and older may be enrolled if clinically indicated for the diagnosis of a proband.

    EXCLUSION CRITERIA:
    • Anyone under the age of 18 years old

    • Any medical, physical, psychiatric, or social conditions, which, in the opinion of the investigators, would make participation in this protocol not in the best interest of the subject. Subjects who are critically ill, unstable, or with severe organ failure that may affect/limit the endocrine evaluation and place unsustainable demands on Clinical Center or NIDDK resources.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 National Institutes of Health Clinical Center Bethesda Maryland United States 20892

    Sponsors and Collaborators

    • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    Investigators

    • Principal Investigator: Marissa F Lightbourne, M.D., National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
    ClinicalTrials.gov Identifier:
    NCT02830308
    Other Study ID Numbers:
    • 160125
    • 16-DK-0125
    First Posted:
    Jul 12, 2016
    Last Update Posted:
    Aug 19, 2022
    Last Verified:
    Aug 15, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 19, 2022